FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.
Sarcoma NGS Testing - Mayo Clinic Laboratories
n order to aid in the diagnosis for a wide range of tumors, our sarcoma NGS panel includes fusions in 138 individual genes.
What's New in Health Care Reform: Dec. 5 - Insights
Top highlights include: Minnesota OKs medical marijuana to treat Alzheimer's, U.S. life expectancy declines again, polio-like disease in U.S. kids appears to have peaked for 2018, methamphetamine use by pregnant women, and the effects of...
Feb. 1986: Mayo Clinic's Year-Old Liver Transplant Program - Insights
In 1986, Mayo Clinic's year-old liver transplant program was growing to be one of the largest in the world. Take a step back to 1986 by reading this article from the February issue of Mayovox.
HCV Treatment_(Interferon-Free).indd
05/2019© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Chronic Hepatitis C Treatment and Monitoring Algorithm: Direct Antiviral Agent (DAA) Combination * www.hcvguidelines.org Treatment failure STOP...
MCL Urine Preservative Chart MC123587
MCL Urine Preservative Chart Urine Preservatives Collection Transportation 24 Hour Urine Specimens Department Laboratory Medicine Pathology Clinic
MCL Urine PreservativesCollection and Transportation for 24Hour Urine Specimens MC123587
MCL Urine PreservativesCollection Transportation 24Hour Urine Specimens Urine Preservatives Collection Transportation 24 Hour Urine Specimens Department Laboratory Medicine Pathology Clinic
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
https://news.mayocliniclabs.com/file-ai-antibody-matrix/
The evolution of phenotype-specific antibody testing Autoimmune neurology testing is rapidly evolving, with increasing numbers of clinically relevant biomarkers discovered each year. Mayo Clinic’s Neuroimmunology Laboratory has developed...